Randomised phase 3 trial: tegoprazan, a novel potassium‐competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis

por Lee, Kwang Jae, Son, Byoung Kwan, Kim, Gwang Ha, Jung, Hye‐Kyung, Jung, Hwoon‐Yong, Chung, Il‐Kwun, Sung, In‐Kyung, Kim, Jin Il, Kim, Jong Hyeok, Lee, Joon Seong, Kwon, Joong Goo, Park, Jung Ho, Huh, Kyu Chan, Park, Kyung Sik, Park, Moo‐In, Kim, Nayoung, Lee, Oh Young, Jee, Sam Ryong, Lee, Sang Kil, Youn, Sei Jin, Kim, Sung Kook, Lee, Soo Teik, Hong, Su Jin, Choi, Suck Chei, Kim, Tae Nyeun, Youn, Young Hoon, Park, Hyo Ju, Kang, Min Ja, Park, Chi Hye, Kim, Bong Tae, Youn, Sangjun, Song, Geun Seog, Rhee, Poong‐Lyul
Publicado 2019